Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rxo (RXO) EPS (Weighted Average and Diluted) (2021 - 2025)

Rxo's EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.27 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 1250.0% year-over-year to -$0.27; the TTM value through Dec 2025 reached -$0.58, up 71.29%, while the annual FY2025 figure was -$0.59, 72.81% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.27 in Q4 2025 per RXO's latest filing, down from -$0.08 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q2 2022 to a low of -$1.81 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.07, with a median of -$0.02 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 125.0% in 2023, then tumbled 18000.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.36 in 2021, then crashed by 111.11% to -$0.04 in 2022, then skyrocketed by 125.0% to $0.01 in 2023, then tumbled by 300.0% to -$0.02 in 2024, then tumbled by 1250.0% to -$0.27 in 2025.
  • Per Business Quant, the three most recent readings for RXO's EPS (Weighted Average and Diluted) are -$0.27 (Q4 2025), -$0.08 (Q3 2025), and -$0.05 (Q2 2025).